An antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering hope that the same approach could be used to combat COVID-19.

A COVID-19 treatment from Regeneron Pharmaceuticals that consists of a pair ... In lab experiments, the researchers found that nine times fewer antibodies within the cocktail bind to B.1.351’s ...

Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%. The US pharma said that the results were a ...